LIRA PALEN: Open Payments
NPI 1548967813 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 18 payments from 9 companies in 2025. Trend: 2023 $757 · 2024 $249 · 2025 $789
Food & beverage: $589Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $254 |
| United Therapeutics Corporation | 4 | $212 |
| Actelion Pharmaceuticals US, Inc. | 2 | $151 |
| BridgeBio Pharma, Inc. | 1 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Liquidia Technologies, Inc. | 1 | $18 |
Products named: Adempas, UPTRAVI, REMODULIN, Tyvaso, Attruby, LEQVIO, VYNDAQEL, WAINUA.
Industry payments across IL — which companies pay providers there.
